Viewing Study NCT03899792


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-02-26 @ 8:12 PM
Study NCT ID: NCT03899792
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-23
First Post: 2019-02-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Medullary Thyroid Cancer View
None Infantile Myofibromatosis View
None Infantile Fibrosarcoma View
None Papillary Thyroid Cancer View
None Soft Tissue Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Loxo View
None LOXO-292 View
None KIF5B-RET View
None M918T View
None CCDC6-RET View
None RET-PTC1 View
None NCOA4-RET View
None RET-PTC View
None RET-PTC3 View
None RET-PTC4 View
None PRKAR1A-RET View
None RET-PTC2 View
None GOLGA5-RET View
None RET-PTC5 View
None ERC1-RET View
None KTN1-RET View
None RET-PTC8 View
None HOOK3-RET View
None PCM1-RET View
None TRIM24-RET View
None RET-PTC6 View
None TRIM27-RET View
None TRIM33-RET View
None RET-PTC7 View
None AKAP13-RET View
None FKBP15-RET View
None SPECC1L-RET View
None TBL1XR1-RET View
None BCR-RET View
None FGRF1OP-RET View
None RFG8-RET View
None RET-PTC9 View
None ACBD5-RET View
None MYH13-RET View
None CUX1-RET View
None KIAA1468-RET View
None FRMD4A-RET View
None SQSTM1-RET View
None AFAP1L2-RET View
None PPFIBP2-RET View
None EML4-RET View
None PARD3-RET View
None G533C View
None C609F View
None C609G View
None C609R View
None C609S View
None C609Y View
None C611F View
None C611G View
None C611S View
None C611Y View
None C611W View
None C618F View
None C618R View
None C618S View
None C620F View
None C620R View
None C620S View
None C630R View
None C630Y View
None D631Y View
None C634F View
None C634G View
None C634R View
None C634S View
None C634W View
None C634Y View
None K666E View
None E768D View
None L790F View
None V804L View
None V804M View
None A883F View
None S891A View
None R912P View
None CLIP1-RET View
None Y806C View
None RET fusion View
None RET alteration View
None RET mutation View
None RET rearrangement View
None RET translocation View
None Neoplasms by Site View
None Neoplasms View
None Non-Small Cell Lung Cancer View
None Lung Neoplasms View
None Carcinoma, Non-Small-Cell Lung View
None Cancer of Lung View
None Cancer of the Lung View
None Lung Cancer View
None Neoplasms, Lung View
None Neoplasms, Pulmonary View
None Pulmonary Cancer View
None Pulmonary Neoplasms View
None Respiratory Tract Neoplasms View
None Lung Diseases View
None Respiratory Tract Diseases View
None Carcinoma, Bronchogenic View
None Bronchial Neoplasms View
None Medullary Thyroid Cancer View
None Papillary Thyroid Cancer View
None Thyroid Diseases View
None Thyroid Neoplasms View
None Cancer of the Thyroid View
None Cancer of Thyroid View
None Neoplasms, Thyroid View
None Thyroid Adenoma View
None Thyroid Cancer View
None Thyroid Carcinoma View
None Endocrine System Diseases View
None Endocrine Gland Neoplasms View
None Head and Neck Neoplasms View
None Thoracic Neoplasms View
None CNS tumor View
None Primary CNS tumor View
None Colonic Neoplasms View
None Cancer of Colon View
None Cancer of the Colon View
None Colon Cancer View
None Colon Neoplasms View
None Colonic Cancer View
None Neoplasms, Colonic View
None Malignant tumor of Breast View
None Mammary Cancer View
None Mammary Carcinoma, Human View
None Mammary Neoplasm, Human View
None Neoplasms, Breast View
None Tumors, Breast View
None Human Mammary Carcinoma View
None Malignant Neoplasm of Breast View
None Breast Carcinoma View
None Breast Tumors View
None Cancer of the Breast View
None Breast Neoplasms View
None Breast Cancer View
None RET Inhibitor View
None MTC View
None NSCLC View
None Soft tissue sarcoma View
None Infantile Myofibromatosis View
None Infantile Fibrosarcoma View